UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Jay Moon Lee, M.D.

Specialty:

Thoracic Surgery/Cardiothoracic Surgery

General Information:

Gender:	Male
Language(s):	English

Affiliation(s):

Surgical Director, Thoracic Oncology Program

Assistant Professor, Department of Surgery, Cardiothoracic Surgery, Surgical Oncology, General Thoracic Surgery, Sarcoma Program

Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:	CardioThoracic Surgery, Brigham and Women's Hospital, 2004 - 2006
Residency:	Surgery, Duke University Medical Center, 2001 - 2004 Surgery, Georgetown University Medical Center, 1998 - 1999
Internship:	Surgery, Georgetown University Medical Center, 1997 - 1998
Medical Degree:	M.D., UCLA School of Medicine, 1997

Certification(s):

Medical Board Certification(s):	Surgery, American Board of Surgery, 2004 Surgery, American Board of Thoracic Surgery, 2009

Contact Information:

Surgery:	(310) 794-7788 Patient appointments
Thoracic Surgery:	(310) 794-7333 Patient appointments (310) 825-9111 Medical center operator (310) 825-6301 Medical center page operator
General Thoracic Surgery:	(310) 794-7333 Information and patient appointments
Lung Cancer Program:	(310) 794-7333 Patient appointments
Thoracic Oncology Program:	(310) 794-7333 Information and referral (310) 206-6909 Information and referral
UCLA Sarcoma Program:	(310) 825-7086 Information and referral
Email:	jaymoonlee@mednet.ucla.edu
Website:	http://www.surgery.medsch.ucla.edu/thoracic/doctors_Lee.shtml

Practice Information:

Clinical Interest(s):	Esophageal Lung Lung Cancer and Chest Malignancies Mesothelioma Sarcoma Thoracic Thoracic Cancer Thymus Trachea

Scientific Interest(s):

Dr. Jay Lee is interested in immunotherapy and gene therapy in lung cancer and the application of nanotechnology as a treatment and imaging modality in lung cancer.

Selected Cancer-Related Publications:

Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am J Transl Res. 2010 Jun 30;2(4):356-67.

Dubinett SM, Lee JM, Sharma S, Mulé JJ. Chemokines: can effector cells be redirected to the site of the tumor? Cancer J. 2010 Jul-Aug;16(4):325-35.

Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, Magyar CE, Dohadwala M, Lee JM, St John MA, Strieter RM, Sharma S, Dubinett SM. Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res. 2009 Nov 15;15(22):6820-9. Epub 2009 Nov 3.

Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol. 2008 Jun;66(3):208-17. Epub 2008 Mar 4. Review.

Lee JM, Mao JT, Krysan K, Dubinett SM. Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC. Future Oncol. 2007 Apr; 3(2):149-153.